Table 2

Visual and anatomical outcomes for 2 years

Overall2010–20122011–20132012–20142013–20152014–20162015–2017P value for ANOVAP value for trend test
Baseline BCVA (logMAR)0.44±0.370.46±0.330.51±0.410.44±0.350.44±0.360.40±0.350.43±0.380.0030.002
Good/poor (eyes)735/131438/9882/203129/236195/356198/27093/1510.002<0.001
Final BCVA (logMAR)0.40±0.420.49±0.390.45±0.440.44±0.430.41±0.480.33±0.350.30±0.36<0.001<0.001
Good/poor (eyes)949/110048/88119/166140/225256/295242/226144/100<0.001<0.001
Difference of BCVA−0.04±0.400.03±0.41−0.06±0.380.00±0.43−0.03±0.45−0.07±0.34−0.13±0.31<0.001<0.001
P value<0.0010.35270.00550.95230.1107<0.001<0.001
95% CI (logMAR)−0.0622 to −0.0278−0.0372 to 0.1035−0.1078 to −0.0188−0.0427 to 0.0454−0.0680 to 0.0070−0.0978 to −0.0361−0.1658 to −0.0884
Baseline CMT (μm)443.8±154.8435.7±165.8447.3±155.9456.1±158.1446.1±161.1441.1±151.5425.9±131.80.2790.180
Final CMT (μm)335.6±139.6347.9±158.3335.5±134.4354.0±151.8327.3±149.3331.3±130.4328.9±104.60.0700.059
Difference of CMT (μm)−108.2±186.8−87.8±213.6−111.8±192.1−102.1±198.9−118.8±186.2−109.8±183.5−97.1±150.70.4560.766
P value<0.001<0.001<0.001<0.001<0.001<0.001<0.001
95% CI (logMAR)−116.3 to −100.0−124.9 to −50.7−134.7 to −88.9−122.7 to −81.5−134.5 to −103.1−126.5 to −93.1−116.1 to −78.0
  • Data were presented as mean value ±SD.

  • ANOVA, analysis of variance; BCVA, best corrected visual acuity; CMT, central macular thickness.